Dataset for amiodarone adverse events compared to placebo using data from randomized controlled trials
Related Experiment Video
Updated: Jan 1, 2026

Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish
Published on: August 16, 2024
Morgan K Moroi1, Mohammed Ruzieh2, Nader M Aboujamous3
1Penn State College of Medicine, Hershey, PA, USA.
Abstract:
The dataset presented here provides a detailed description of the adverse events of amiodarone versus placebo using data from 43 randomized controlled trials. Two authors (M.M., M.R.) independently extracted the data. The dataset also includes baseline patient characteristics, amiodarone loading and maintenance doses, as well as forest plots describing the relative risk (RR) of developing an adverse event related to the pulmonary, thyroid, hepatic, cardiac, skin, gastrointestinal, neurological, and ocular systems. The Mantel-Haenszel random effects model was used to determine the relative risk of adverse events of amiodarone compared to placebo. This dataset is complementary to our article "Meta-analysis Comparing the Relative Risk of Adverse Events for Amiodarone Versus Placebo", which was published in the American Journal of Cardiology [1]. The data can be used to assess certain adverse events and their relation to amiodarone loading and/or maintenance dose.
More Related Videos
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Hazard Ratio
For example, in a clinical trial...
Clinical Trials: Overview
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Clinical Trials
There are four phases in a clinical trial. A phase one...
Cardiovascular Drugs: Classification based on Therapeutic Indications

